In glioma cells, LPCAT1 induces the conversion of lysophosphatidylcholine from an unsaturated to a saturated state accompanying the remodeling of membrane lipids, resulting in the activation and recruitment of the EGFR pathway, which, in turn, further promotes the biosynthesis of LPCAT1. This evidence concerns the gene LPCAT1 and central nervous system cancer.